Purdue Pharma LP acknowledged in a letter that the maker of the opioid painkiller Oxycontin is in negotiations with state attorneys general over lawsuits accusing the company of creating a public-health crisis with its mishandling of the drug.
Pharmaceutical companies have introduced new medicines to treat dependence, reverse overdoses, and deal with opioids side effects, but few effective alternatives to addictive painkillers have emerged from the laboratory.
Alex Azar isnt likely to shy away from the topic of sky-high medication prices -- but it may be insurers and drug plans that feel the heat as much as his former industry.
President Donald Trump named former Eli Lilly & Co. executive Alex Azar to lead the Department of Health and Human Services after agencys past chief resigned amid blowback over his taxpayer-funded private jet travel.
President Donald Trump on Thursday will declare widespread opioid abuse a public health emergency, while resisting a controversial move that might have tapped federal funds sought by hurricane-stricken Texas, Florida and Puerto Rico.
PhRMA will require members spend at least $200 million a year on research and development and that their R&D spending is at least 10 percent of global sales.
Consumer payments for the two lowest-cost ACA silver plans will rise quickly, a study says.
DebugScreen: mobile
{
"author": {
"name": "Jared S Hopkins",
"webUrl": "/author/profile/jared-s-hopkins/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 19,
"social": [],
"articles": [
{
"uri": "/2017/12/01/purdue-pharma-discloses-negotiations-with-ags-on-o/",
"title": "Purdue Pharma discloses negotiations with AGs on opioids",
"byline": " Jef Feeley, Jared S. Hopkins ",
"kicker": "",
"prettyDate": "December 01, 2017",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley-jared-s-hopkins/",
"name": "Jef Feeley, Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "Purdue Pharma LP acknowledged in a letter that the maker of the opioid painkiller Oxycontin is in negotiations with state attorneys general over lawsuits accusing the company of creating a public-health crisis with its mishandling of the drug.",
"body": null
},
{
"uri": "/2017/11/27/why-drugmakers-arent-interested-in-finding-opioid/",
"title": "Why drugmakers aren't interested in finding opioid alternatives",
"byline": "Jared S. Hopkins",
"kicker": "",
"prettyDate": "November 27, 2017",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "Pharmaceutical companies have introduced new medicines to treat dependence, reverse overdoses, and deal with opioids side effects, but few effective alternatives to addictive painkillers have emerged from the laboratory.",
"body": null
},
{
"uri": "/2017/11/15/new-hhs-director-blames-pbms-insurance-plans-for-h/",
"title": "New HHS director blames PBMs, insurance plans for high drug prices",
"byline": " Anna Edney, Jared S. Hopkins, Natasha Rausch ",
"kicker": "",
"prettyDate": "November 15, 2017",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/anna-edney-jared-s-hopkins-natasha-rausch/",
"name": "Anna Edney, Jared S. Hopkins, Natasha Rausch"
}
],
"kickerNode": [],
"summary": "Alex Azar isnt likely to shy away from the topic of sky-high medication prices -- but it may be insurers and drug plans that feel the heat as much as his former industry.",
"body": null
},
{
"uri": "/2017/11/13/trump-confirms-selection-of-alex-azar-for-health-s/",
"title": "Trump confirms selection of Alex Azar for Health Secretary",
"byline": " Anna Edney, Jared S. Hopkins ",
"kicker": "",
"prettyDate": "November 13, 2017",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/anna-edney-jared-s-hopkins/",
"name": "Anna Edney, Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "President Donald Trump named former Eli Lilly & Co. executive Alex Azar to lead the Department of Health and Human Services after agencys past chief resigned amid blowback over his taxpayer-funded private jet travel.",
"body": null
},
{
"uri": "/2017/10/26/trump-declares-opioid-epidemic-a-public-health-eme/",
"title": "Trump declares opioid epidemic a public health emergency",
"byline": " Margaret Talev, Jared S. Hopkins, Anna Edney ",
"kicker": "",
"prettyDate": "October 26, 2017",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/margaret-talev-jared-s-hopkins-anna-edney/",
"name": "Margaret Talev, Jared S. Hopkins, Anna Edney"
}
],
"kickerNode": [],
"summary": "President Donald Trump on Thursday will declare widespread opioid abuse a public health emergency, while resisting a controversial move that might have tapped federal funds sought by hurricane-stricken Texas, Florida and Puerto Rico.",
"body": null
},
{
"uri": "/2017/07/07/opioid-prescriptions-ebb-but-addiction-overdoses-s/",
"title": "Opioid prescriptions ebb but addiction, overdoses still vex U.S.",
"byline": " Jared S. Hopkins, Justin Mattingly ",
"kicker": "",
"prettyDate": "July 07, 2017",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins-justin-mattingly/",
"name": "Jared S. Hopkins, Justin Mattingly"
}
],
"kickerNode": [],
"summary": "Of the more than 50,000 drug-related deaths in the U.S. in 2015, close to two-thirds involved opioids, according to the CDC.",
"body": null
},
{
"uri": "/2017/05/10/pharma-lobby-ousts-22-drugmakers-amid-u-s-pricing/",
"title": "Pharma lobby ousts 22 drugmakers amid U.S. pricing debate",
"byline": " Jared S. Hopkins ",
"kicker": "",
"prettyDate": "May 10, 2017",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "PhRMA will require members spend at least $200 million a year on research and development and that their R&D spending is at least 10 percent of global sales.",
"body": null
},
{
"uri": "/2016/12/07/trumps-vow-to-control-drug-costs-puts-another-indu/",
"title": "Trump’s vow to control drug costs puts another industry on alert",
"byline": " Jared S. Hopkins ",
"kicker": "",
"prettyDate": "December 07, 2016",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "Investors believed the election of Trump would be a boon for free-market health care, but now Trump is going after big pharma.",
"body": null
},
{
"uri": "/2016/06/15/premiums-on-popular-obamacare-plans-may-rise-10-in/",
"title": "Premiums on popular Obamacare plans may rise 10% in 2017",
"byline": " Jared S. Hopkins ",
"kicker": "",
"prettyDate": "June 15, 2016",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "Consumer payments for the two lowest-cost ACA silver plans will rise quickly, a study says.",
"body": null
}
]
}
}
